speb/financial-data huggingface dataset:
Financial ratios for HFCL.NS — quarterly report dated 2025-06-30
Total revenue: 101921366.72127312
Gross profit: 27607067.63398081
Operating income: -444652.468991341
Net income: -3428504.563538498
Capital expenditures: 0
Depreciation & amortization: 3767844.6056634686
Owner earnings: 339340.0421249708
Buffett classification: The Gruesome
Stock price: 1.0112333255324129
P/E ratio: 346.7498910226108
Shares outstanding: 1530263663
Market cap (USD): 1547453612.8769016
Interest coverage ratio: -0.06832074793239842
COGS to revenue (%): 72.91336593878441
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.881428081448
Rule of 40 score: 8.881428081448
Financial ratios for HFCL.NS — quarterly report dated 2025-12-31
Total revenue: 134876907.6528907
Gross profit: 50917901.303330734
Operating income: 20533585.83045561
Net income: 11403586.944413502
Capital expenditures: 0
Depreciation & amortization: 4875793.6949983295
Owner earnings: 16279380.639411831
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7551520552523115
P/E ratio: 164.13403709266447
Shares outstanding: 1530263663
Market cap (USD): 1155581750.1923807
Effective tax rate (%): 25.877923394395776
Interest coverage ratio: 2.937061822817081
COGS to revenue (%): 62.248614540919576
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 32.334280820371966
Rule of 40 score: 32.334280820371966
Financial ratios for HSTR.V — annual report dated 2022-03-31
Total revenue: 0
Gross profit: -42238.4
Operating income: -7950347.792
Net income: -7981834.256
Capital expenditures: 224194.92799999999
Operating cash flow: -6485185.272
Depreciation & amortization: 33832.4
Net tangible assets: 6587648.143999999
Owner earnings: -8172196.784
Return on net tangible assets (%): -124.05332837096348
Buffett classification: The Gruesome
Stock price: 0.36
Shares outstanding: 279319475
Book value: 6587648.144
P/B ratio: 15.264174528140977
Market cap (USD): 100555011
Debt to equity: 0
Current ratio: 1.0043458229866655
Quick ratio: 1.0043458229866655
Free cash flow (dilution-adjusted): -7390799.552
Buyback yield (%): 0
Retained earnings: -33303230.544
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -120.68567747111905
Rule of 40 score: 0
Financial ratios for HSTR.V — annual report dated 2023-03-31
Total revenue: 0
Gross profit: -21363.7037037037
Operating income: -2364462.407407407
Net income: -2481753.111111111
Capital expenditures: 65774.55555555555
Operating cash flow: -3073448.1185185183
Depreciation & amortization: 15794.548148148147
Net tangible assets: 16276296.296296295
Owner earnings: -2531733.1185185183
Return on net tangible assets (%): -15.554724935147682
Buffett classification: The Gruesome
Stock price: 0.2296296296296296
Shares outstanding: 279319475
Book value: 16276296.296296295
P/B ratio: 3.9407016452009285
Market cap (USD): 64140027.59259258
Debt to equity: 0
Current ratio: 5.105263157894736
Quick ratio: 5.105263157894736
Free cash flow (dilution-adjusted): -3826789.555555556
Buyback yield (%): 0
Retained earnings: -35329629.62962963
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.331763981121833
Rule of 40 score: 0
Financial ratios for HSTR.V — annual report dated 2024-03-31
Total revenue: 0
Gross profit: 0
Operating income: -10725185.185185185
Net income: -10948888.888888888
Capital expenditures: 54814.81481481481
Operating cash flow: -8151111.111111111
Depreciation & amortization: 87407.4074074074
Net tangible assets: 12694814.814814813
Owner earnings: -10916296.296296297
Return on net tangible assets (%): -85.9901972225464
Buffett classification: The Gruesome
Stock price: 0.1838235294117647
Shares outstanding: 279319475
Book value: 12694814.814814813
P/B ratio: 4.044603444551324
Market cap (USD): 51345491.72794117
Debt to equity: 0
Current ratio: 0.23377804730139481
Quick ratio: 0.23377804730139481
Interest coverage ratio: -75.02072538860104
Free cash flow (dilution-adjusted): -9252592.592592591
Buyback yield (%): 0
Retained earnings: -46278518.518518515
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -82.10842690257458
Rule of 40 score: 0
Financial ratios for HSTR.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 18484.57037037037
Buffett classification: The Gruesome
Stock price: 0.36296296296296293
Shares outstanding: 279319475
Market cap (USD): 101382624.25925925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HSTR.V — quarterly report dated 2024-12-31
Operating income: 1255203.8041958043
Capital expenditures: 1286952.6503496505
Depreciation & amortization: 16113.461538461539
Capex to operating income (%): 102.52937778293203
Buffett classification: The Gruesome
Stock price: 0.42657342657342656
Shares outstanding: 279319475
Market cap (USD): 119150265.55944055
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HSTR.V — quarterly report dated 2025-03-31
Total revenue: 16047597.734265735
Gross profit: 8333110.258741259
Operating income: 3346035.8251748257
Net income: -22397805.545454547
Capital expenditures: 935903.6993006994
Operating cash flow: 6493979.909090909
Depreciation & amortization: 1063547.2517482517
Net tangible assets: 43036363.63636364
Owner earnings: -22270161.993006993
Return on net tangible assets (%): -51.747313460726005
Capex to operating income (%): 27.97052237932329
Buffett classification: The Good
Stock price: 0.7202797202797203
Shares outstanding: 279319475
Book value: 43036363.63636364
P/B ratio: 4.6748409094602055
Market cap (USD): 201188153.32167834
Debt to equity: 0.0017386500276234114
Current ratio: 3.0841549295774646
Quick ratio: 1.8005030181086519
Interest coverage ratio: 2.827667819775317
COGS to revenue (%): 48.07253772975669
SG&A to revenue (%): 22.141331406980047
Free cash flow (dilution-adjusted): 7194205.545454546
Buyback yield (%): 0
Retained earnings: -28979720.27972028
Inventory turnover: 0.4322942548689212
Receivables turnover: 4.0920229600570615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.915282836480185
FCF margin (%): 44.83042050644797
Rule of 40 score: 44.83042050644797
Financial ratios for HSTR.V — annual report dated 2025-03-31
Total revenue: 25576223.77622378
Gross profit: 12992307.692307692
Operating income: 32867.13286713287
Net income: 14709790.209790211
Capital expenditures: 410489.5104895105
Operating cash flow: 4092307.6923076925
Depreciation & amortization: 1111888.111888112
Net tangible assets: 43036363.63636364
Owner earnings: 15411188.811188813
Return on net tangible assets (%): 35.80969094277079
Capex to operating income (%): 1248.936170212766
Buffett classification: The Gruesome
Stock price: 0.7202797202797203
P/E ratio: 13.67715993582125
Shares outstanding: 279319475
Book value: 43036363.63636364
P/B ratio: 4.6748409094602055
Market cap (USD): 201188153.32167834
Debt to equity: 0.0017386500276234114
Current ratio: 3.0841549295774646
Quick ratio: 1.8005030181086519
Effective tax rate (%): 23.46177637084743
Interest coverage ratio: 0.023118544023610424
COGS to revenue (%): 49.20161863618964
SG&A to revenue (%): 28.673374528353474
Free cash flow (dilution-adjusted): 2562237.7622377626
Buyback yield (%): 0
Retained earnings: -28979720.27972028
Inventory turnover: 0.7051608605352875
Receivables turnover: 6.521754636233952
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.048281388038542934
FCF margin (%): 10.018045606168316
Rule of 40 score: 10.018045606168316
Financial ratios for HSTR.V — quarterly report dated 2025-06-30
Total revenue: 20383941.605839413
Gross profit: 10405839.416058393
Operating income: 5485401.459854014
Net income: 1381021.8978102189
Capital expenditures: 0
Operating cash flow: 426277.3722627737
Depreciation & amortization: 697810.2189781021
Net tangible assets: 48129927.00729927
Owner earnings: 2078832.116788321
Return on net tangible assets (%): 4.319208953865752
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9197080291970803
P/E ratio: 46.5040352140592
Shares outstanding: 279319475
Book value: 48129927.00729926
P/B ratio: 5.337476697807031
Market cap (USD): 256892363.86861312
Debt to equity: 0
Current ratio: 3.823654739142311
Quick ratio: 2.416771373941546
Effective tax rate (%): 68.95306859205775
Interest coverage ratio: 326.73913043478257
COGS to revenue (%): 48.95079853899592
SG&A to revenue (%): 11.351428776050993
Free cash flow (dilution-adjusted): 135766.4233576642
Buyback yield (%): 0
Retained earnings: -28867883.21167883
Inventory turnover: 0.5308119442395062
Receivables turnover: 2.4355485784057214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.181903323840288
FCF margin (%): 0.6660459786578815
Revenue growth (%): 27.021763278091594
Rule of 40 score: 27.687809256749475
Financial ratios for HSTR.V — quarterly report dated 2025-09-30
Total revenue: 19255395.68345324
Gross profit: 10246762.589928059
Operating income: 2901438.8489208636
Net income: 903597.1223021584
Capital expenditures: 0
Operating cash flow: 3669064.748201439
Depreciation & amortization: 786330.9352517986
Net tangible assets: 48560431.654676266
Owner earnings: 1689928.057553957
Return on net tangible assets (%): 3.4800515563193524
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3093525179856116
P/E ratio: 101.18659325238852
Shares outstanding: 279319475
Book value: 48560431.65467626
P/B ratio: 7.531392235440526
Market cap (USD): 365727657.9136691
Debt to equity: 0
Current ratio: 2.4951655247486713
Quick ratio: 1.5903502593327783
Effective tax rate (%): 76.02595915251003
Interest coverage ratio: 183.3181818181818
COGS to revenue (%): 46.78498038483093
SG&A to revenue (%): 10.831309546048946
Free cash flow (dilution-adjusted): 3277697.841726619
Buyback yield (%): 0
Retained earnings: -27548920.863309354
Inventory turnover: 0.4430841088425746
Receivables turnover: 2.2618947012591906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.088314900605189
FCF margin (%): 17.022230524939285
Revenue growth (%): -5.5364460132817355
Rule of 40 score: 11.485784511657549
Financial ratios for HSTR.V — quarterly report dated 2025-12-31
Total revenue: 27104379.562043793
Gross profit: 13758394.160583941
Operating income: 4213138.686131386
Net income: 6758394.160583941
Capital expenditures: 5538686.131386861
Operating cash flow: 7484671.532846714
Depreciation & amortization: 751824.8175182481
Net tangible assets: 58717518.24817518
Owner earnings: 1971532.8467153283
Return on net tangible assets (%): 3.3576569745036857
Capex to operating income (%): 131.46223146223147
Buffett classification: The Gruesome
Stock price: 1.846715328467153
P/E ratio: 19.080847600982825
Shares outstanding: 279319475
Book value: 58717518.248175174
P/B ratio: 8.784832387529057
Market cap (USD): 515823556.02189773
Debt to equity: 0
Current ratio: 2.316431874395096
Quick ratio: 1.551672222819658
Effective tax rate (%): -40.821292775665405
Interest coverage ratio: 288.59999999999997
COGS to revenue (%): 49.23922117792798
SG&A to revenue (%): 11.089866156787764
Free cash flow (dilution-adjusted): 1735766.4233576641
Buyback yield (%): 0
Retained earnings: -21192700.729927007
Inventory turnover: 0.6427617239682204
Receivables turnover: 2.8805368086261733
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.3329391220792175
FCF margin (%): 6.404007217299975
Revenue growth (%): 40.76251668687043
Rule of 40 score: 47.166523904170404
Financial ratios for IEX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.749307661875247
Shares outstanding: 889300290
Market cap (USD): 2444960101.004879
Buyback yield (%): 0
Retained earnings: 79031438.7445602
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEX.NS — annual report dated 2023-03-31
Total revenue: 48794336.17539586
Gross profit: 45190377.58830695
Operating income: 38732838.00243606
Net income: 37257771.01096224
Capital expenditures: 1064056.029232643
Operating cash flow: -2754957.3690621196
Depreciation & amortization: 2264470.1583434837
Net tangible assets: 86516248.47746651
Owner earnings: 38458185.14007308
Return on net tangible assets (%): 44.45197961870673
Capex to operating income (%): 2.74716773701354
Buffett classification: The Great
Stock price: 1.4548112058465288
P/E ratio: 34.724676011184556
Shares outstanding: 889300290
Book value: 97332034.1047503
P/B ratio: 13.292273598866721
Market cap (USD): 1293764027.2545679
Debt to equity: 0.017641810245577504
Current ratio: 1.2641106880851996
Quick ratio: 1.2641106880851996
Effective tax rate (%): 23.87581770589913
Interest coverage ratio: 129.4510889476898
COGS to revenue (%): 7.386018275018939
SG&A to revenue (%): 2.7872336973276433
Free cash flow (dilution-adjusted): -3907953.71498173
Buyback yield (%): 1.148253303708296
Retained earnings: 84421656.51644337
Receivables turnover: 56.953780317893596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.72351570317445
FCF margin (%): -8.009031419003673
Rule of 40 score: -8.009031419003673
Financial ratios for IEX.NS — annual report dated 2024-03-31
Total revenue: 53822856.45760883
Gross profit: 49796354.47895431
Operating income: 42746948.07530879
Net income: 42065307.59083823
Capital expenditures: 1749058.6401247152
Operating cash flow: 35790910.18107687
Depreciation & amortization: 2455174.4813526804
Net tangible assets: 106412483.51121238
Owner earnings: 42771423.432066195
Return on net tangible assets (%): 40.19399042365128
Capex to operating income (%): 4.091657343685302
Buffett classification: The Great
Stock price: 1.5274712092130518
P/E ratio: 32.29218249234129
Shares outstanding: 889300290
Book value: 116581280.72910422
P/B ratio: 11.65178989992603
Market cap (USD): 1358380589.3198175
Debt to equity: 0.0106599526235757
Current ratio: 1.5753334666019667
Quick ratio: 1.5753334666019667
Effective tax rate (%): 24.747904775205395
Interest coverage ratio: 125.74671934528008
COGS to revenue (%): 7.481026173008505
SG&A to revenue (%): 2.4115876699534433
Free cash flow (dilution-adjusted): 33949502.33840988
Buyback yield (%): 0
Retained earnings: 103861122.43674302
Receivables turnover: 567.7065519858335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.86925940087957
FCF margin (%): 63.07636675721343
Revenue growth (%): 10.305540922080532
Rule of 40 score: 73.38190767929396
Financial ratios for IEX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 115179813.66459627
Buffett classification: The Gruesome
Stock price: 2.3352842809364547
Shares outstanding: 889300290
Book value: 124752699.47443861
P/B ratio: 16.647086572220857
Market cap (USD): 2076768988.2692306
Debt to equity: 0.007835760303997512
Current ratio: 1.8023162724127024
Quick ratio: 1.8023162724127024
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEX.NS — quarterly report dated 2024-12-31
Total revenue: 15392586.54854878
Gross profit: 14045786.222170414
Operating income: 12554167.152348757
Net income: 12506411.003613474
Capital expenditures: 0
Depreciation & amortization: 630143.3733535376
Owner earnings: 13136554.376967011
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0279752884951625
P/E ratio: 36.05109034979146
Shares outstanding: 889300290
Market cap (USD): 1803479012.1715817
Effective tax rate (%): 23.060678031248298
Interest coverage ratio: 160.5099850968703
COGS to revenue (%): 8.74966869363059
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEX.NS — annual report dated 2025-03-31
Total revenue: 62808311.900865085
Gross profit: 57414531.21346738
Operating income: 50551402.85246668
Net income: 50171744.21323357
Capital expenditures: 898421.7909749824
Operating cash flow: 49947533.31774608
Depreciation & amortization: 2484404.956745382
Net tangible assets: 123987374.32779986
Owner earnings: 51757727.379003964
Return on net tangible assets (%): 41.74435313241333
Capex to operating income (%): 1.7772440333594888
Buffett classification: The Great
Stock price: 1.9801610456295953
P/E ratio: 35.09859622661121
Shares outstanding: 889300290
Book value: 132838800.56114097
P/B ratio: 13.256351191718236
Market cap (USD): 1760957792.1251023
Debt to equity: 0.005416424543768296
Current ratio: 1.5734029732092853
Quick ratio: 1.5734029732092853
Effective tax rate (%): 23.978435387645785
Interest coverage ratio: 165.24636961173954
COGS to revenue (%): 8.587686126497243
SG&A to revenue (%): 1.7993631788420668
Free cash flow (dilution-adjusted): 48837234.04255319
Buyback yield (%): 0
Retained earnings: 120286368.95019872
Receivables turnover: 205.06977365548303
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.33478369958849
FCF margin (%): 77.75600484158296
Revenue growth (%): 16.69449753253667
Rule of 40 score: 94.45050237411964
Financial ratios for IEX.NS — quarterly report dated 2025-03-31
Total revenue: 16629436.520925881
Gross profit: 15293231.236848257
Operating income: 13565782.090250174
Net income: 13690986.672901565
Capital expenditures: 0
Depreciation & amortization: 616635.4921674071
Net tangible assets: 123987374.32779986
Owner earnings: 14307622.165068973
Return on net tangible assets (%): 11.539579931132542
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9801610456295953
P/E ratio: 32.15542155939989
Shares outstanding: 889300290
Book value: 132838800.56114097
P/B ratio: 13.256351191718236
Market cap (USD): 1760957792.1251023
Debt to equity: 0.005416424543768296
Current ratio: 1.5734029732092853
Quick ratio: 1.5734029732092853
Effective tax rate (%): 22.954198573721747
Interest coverage ratio: 189.33219122205907
COGS to revenue (%): 8.03518076151403
Buyback yield (%): 0
Retained earnings: 120286368.95019872
Receivables turnover: 54.295278445742206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.750664277379983
Revenue growth (%): 8.03536149350878
Rule of 40 score: 8.03536149350878
Financial ratios for IEX.NS — quarterly report dated 2025-06-30
Total revenue: 16586871.050783994
Gross profit: 15148350.105312428
Operating income: 12855172.010297216
Net income: 14123180.435291365
Capital expenditures: 0
Depreciation & amortization: 637257.1963491692
Owner earnings: 14760437.631640535
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1979873625087762
P/E ratio: 48.478243379229625
Shares outstanding: 889300290
Market cap (USD): 1954670798.8953898
Effective tax rate (%): 23.79825873944858
Interest coverage ratio: 189.41431034482758
COGS to revenue (%): 8.672648030284003
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.25596459680593997
Rule of 40 score: -0.25596459680593997
Financial ratios for IEX.NS — quarterly report dated 2025-12-31
Total revenue: 16226801.826890944
Gross profit: 14773654.895844938
Operating income: 12909346.106717167
Net income: 13267817.756488806
Capital expenditures: 0
Depreciation & amortization: 673599.1979503175
Owner earnings: 13941416.954439122
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4543834243065612
P/E ratio: 24.135516282028313
Shares outstanding: 889300290
Market cap (USD): 1293383601.0070179
Effective tax rate (%): 24.10597427489642
Interest coverage ratio: 222.389560545001
COGS to revenue (%): 8.955226954444354
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.170808603929136
Rule of 40 score: -2.170808603929136
Financial ratios for IMC.V — annual report dated 2021-12-31
Total revenue: 0
Gross profit: 0
Operating income: -1076308.661417323
Net income: -1058573.2283464568
Capital expenditures: 132629.92125984252
Operating cash flow: -985637.0078740157
Depreciation & amortization: 0
Net tangible assets: 2451538.5826771655
Owner earnings: -1191203.1496062994
Return on net tangible assets (%): -48.59002252803478
Buffett classification: The Gruesome
Stock price: 0.11023622047244096
Shares outstanding: 95248830
Book value: 2436876.377952756
P/B ratio: 4.3087417640951875
Market cap (USD): 10499871.023622049
Debt to equity: 0
Current ratio: 8.038606073471449
Quick ratio: 8.038606073471449
Free cash flow (dilution-adjusted): -1301899.2125984253
Buyback yield (%): 0
Retained earnings: -1509044.8818897638
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.167552821105375
Rule of 40 score: 0
Financial ratios for IMC.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -1083.8235294117646
Operating income: -804205.8823529411
Net income: -1269949.2647058822
Capital expenditures: 657427.9411764705
Operating cash flow: -656448.5294117647
Depreciation & amortization: 1083.8235294117646
Net tangible assets: 1271321.3235294116
Owner earnings: -1926293.3823529407
Return on net tangible assets (%): -151.5190020572621
Buffett classification: The Gruesome
Stock price: 0.03676470588235294
Shares outstanding: 95248830
Book value: 1217230.1470588234
P/B ratio: 2.8768554813151606
Market cap (USD): 3501795.220588235
Debt to equity: 0
Current ratio: 9.269278657100116
Quick ratio: 9.269278657100116
Free cash flow (dilution-adjusted): -802457.3529411764
Buyback yield (%): 0
Retained earnings: -2679130.882352941
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.06851500483559
Rule of 40 score: 0
Financial ratios for IMC.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -1116.6666666666665
Operating income: -504919.69696969696
Net income: -510200
Capital expenditures: 37878.78787878788
Operating cash flow: -476636.3636363636
Depreciation & amortization: 1116.6666666666665
Net tangible assets: 1032640.1515151515
Owner earnings: -546962.1212121212
Return on net tangible assets (%): -52.96734979843517
Buffett classification: The Gruesome
Stock price: 0.030303030303030304
Shares outstanding: 95248830
Book value: 1032640.1515151515
P/B ratio: 2.7950958304140974
Market cap (USD): 2886328.181818182
Debt to equity: 0
Current ratio: 8.528015559054285
Quick ratio: 8.528015559054285
Free cash flow (dilution-adjusted): -550587.8787878788
Buyback yield (%): 0
Retained earnings: -3377383.333333333
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.895996948099345
Rule of 40 score: 0
Financial ratios for IMC.V — quarterly report dated 2024-09-30
Total revenue: 0
Gross profit: -273.3333333333333
Operating income: -766571.8518518518
Net income: -766771.8518518518
Capital expenditures: 68928.14814814815
Operating cash flow: -832971.8518518518
Depreciation & amortization: 273.3333333333333
Net tangible assets: 266849.6296296296
Owner earnings: -835426.6666666665
Return on net tangible assets (%): -313.0701990578686
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 95248830
Book value: 266442.9629629629
P/B ratio: 10.592088919037637
Market cap (USD): 2822187.5555555555
Debt to equity: 0
Current ratio: 0.9382596479277976
Quick ratio: 0.9382596479277976
Free cash flow (dilution-adjusted): -901899.9999999999
Buyback yield (%): 0
Retained earnings: -4290136.296296296
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -287.7057976413547
Rule of 40 score: 0
Financial ratios for IMC.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 95248830
Market cap (USD): 2664302.9370629373
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.V — annual report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 95248830
Market cap (USD): 2664302.9370629373
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -2832.374100719425
Operating income: -67520.1438848921
Net income: -67360.43165467626
Capital expenditures: 0
Operating cash flow: -4671.942446043166
Depreciation & amortization: 2832.374100719425
Net tangible assets: -171416.54676258995
Owner earnings: -64528.05755395683
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
Shares outstanding: 95248830
Book value: -166351.7985611511
Market cap (USD): 2055730.143884892
Debt to equity: -0.13174385565824354
Current ratio: 0.13632640425161402
Quick ratio: 0.13632640425161402
Interest coverage ratio: -128.38987688098496
Free cash flow (dilution-adjusted): -4671.942446043166
Buyback yield (%): 0
Retained earnings: -4651161.870503598
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -2343.795620437956
Operating income: -65046.71532846715
Net income: -63981.02189781021
Capital expenditures: 0
Operating cash flow: -10632.116788321167
Depreciation & amortization: 2343.795620437956
Net tangible assets: -237899.99999999997
Owner earnings: -61637.226277372254
Buffett classification: The Gruesome
Stock price: 0.0218978102189781
Shares outstanding: 95248830
Book value: -233989.7810218978
Market cap (USD): 2085740.8029197077
Debt to equity: -0.09216198848287092
Current ratio: 0.09216488940550194
Quick ratio: 0.09216488940550194
Interest coverage ratio: -350.8425196850394
Free cash flow (dilution-adjusted): -10632.116788321167
Buyback yield (%): 0
Retained earnings: -4783043.065693431
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -10743.795620437955
Operating income: -260164.23357664232
Net income: -257942.33576642335
Capital expenditures: 0
Operating cash flow: -76580.29197080291
Depreciation & amortization: 10743.795620437955
Net tangible assets: -237899.99999999997
Owner earnings: -247198.5401459854
Buffett classification: The Gruesome
Stock price: 0.0218978102189781
Shares outstanding: 95248830
Book value: -233989.7810218978
Market cap (USD): 2085740.8029197077
Debt to equity: -0.09216198848287092
Current ratio: 0.09216488940550194
Quick ratio: 0.09216488940550194
Interest coverage ratio: -145.4202366381069
Free cash flow (dilution-adjusted): -76580.29197080291
Buyback yield (%): 0
Retained earnings: -4783043.065693431
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRX — annual report dated 2021-12-31
Gross profit: 926888
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.17
Shares outstanding: 64697402
Market cap (USD): 1046156990.3400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRX — annual report dated 2022-12-31
Total revenue: 316952
Gross profit: 158830
Operating income: -51745339
Net income: -50513568
Capital expenditures: 742483
Operating cash flow: -44101265
Depreciation & amortization: 277252
Net tangible assets: 102750877
Owner earnings: -50978799
Return on net tangible assets (%): -49.61397945051117
Buffett classification: The Gruesome
Stock price: 4.85
Shares outstanding: 64697402
Book value: 109850255
P/B ratio: 2.856455815236842
Market cap (USD): 313782399.7
Debt to equity: 0.04407529140464899
Current ratio: 13.502095524634814
Quick ratio: 13.502095524634814
COGS to revenue (%): 49.88831116383554
R&D to revenue (%): 11442.463212095206
SG&A to revenue (%): 4924.089452030592
Free cash flow (dilution-adjusted): -48908194
Buyback yield (%): 0
Retained earnings: -109786956
Receivables turnover: 25.525650318112266
Capitalized R&D asset: 36267116
ROCI (R&D-adjusted, %): -18.307345764660408
FCF margin (%): -15430.788889169338
Rule of 40 score: -15430.788889169338
Financial ratios for IMRX — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -58413285
Net income: -53471622
Capital expenditures: 342746
Operating cash flow: -48968634
Depreciation & amortization: 352083
Net tangible assets: 83506072
Owner earnings: -53462285
Return on net tangible assets (%): -64.02203303252007
Buffett classification: The Gruesome
Stock price: 7.35
Shares outstanding: 64697402
Book value: 90576183
P/B ratio: 5.250010421613814
Market cap (USD): 475525904.7
Debt to equity: 0.04927298603430882
Current ratio: 11.354742838030907
Quick ratio: 11.354742838030907
Free cash flow (dilution-adjusted): -55038515
Buyback yield (%): 0
Retained earnings: -163258578
Capitalized R&D asset: 65922985.72
ROCI (R&D-adjusted, %): -26.610507039397163
Rosenberg metric: -0.0043794494163803925
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for IMRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.49
Shares outstanding: 64697402
Market cap (USD): 161096530.98000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.2
Shares outstanding: 64697402
Market cap (USD): 142334284.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -64071655
Net income: -61036608
Capital expenditures: 84875
Operating cash flow: -54999571
Depreciation & amortization: 385074
Net tangible assets: 34345382
Owner earnings: -60736409
Return on net tangible assets (%): -176.84010327793123
Buffett classification: The Gruesome
Stock price: 2.2
Shares outstanding: 64697402
Book value: 41386226
P/B ratio: 3.4391704235124028
Market cap (USD): 142334284.4
Debt to equity: 0.10058556680186302
Current ratio: 5.275692025659642
Quick ratio: 5.275692025659642
Free cash flow (dilution-adjusted): -61585812
Buyback yield (%): 0
Retained earnings: -224295186
Capitalized R&D asset: 87820628.34
ROCI (R&D-adjusted, %): -43.6432022403332
Rule of 40 score: 0
Financial ratios for IMRX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -15485010
Net income: -15046132
Capital expenditures: 8945
Operating cash flow: -14080638
Depreciation & amortization: 92578
Net tangible assets: 34809392
Owner earnings: -14962499
Return on net tangible assets (%): -42.984086019083584
Buffett classification: The Gruesome
Stock price: 1.52
Shares outstanding: 64697402
Book value: 41842920
P/B ratio: 2.350219608000589
Market cap (USD): 98340051.04
Debt to equity: 0.0975725164496168
Current ratio: 7.479408023877002
Quick ratio: 7.479408023877002
Free cash flow (dilution-adjusted): -15781850
Buyback yield (%): 0
Retained earnings: -239341318
Capitalized R&D asset: 11471693
ROCI (R&D-adjusted, %): -13.738698628814225
Rule of 40 score: 0
Financial ratios for IMRX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -14757477
Net income: -14433464
Capital expenditures: 2116
Operating cash flow: -9446124
Depreciation & amortization: 91843
Net tangible assets: 21909826
Owner earnings: -14343737
Return on net tangible assets (%): -65.46714245927832
Buffett classification: The Gruesome
Stock price: 3.37
Shares outstanding: 64697402
Book value: 28936037
P/B ratio: 7.534903440301794
Market cap (USD): 218030244.74
Debt to equity: 0.1382552835414193
Current ratio: 3.7032263321058445
Quick ratio: 3.7032263321058445
Free cash flow (dilution-adjusted): -10973183
Buyback yield (%): 0
Retained earnings: -253775199
Capitalized R&D asset: 18140194.310000002
ROCI (R&D-adjusted, %): -22.898783406895213
Rule of 40 score: 0
Financial ratios for IMRX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -15380300
Net income: -14964469
Capital expenditures: 7255
Operating cash flow: -11977235
Depreciation & amortization: 86157
Net tangible assets: 220957538
Owner earnings: -14885567
Return on net tangible assets (%): -6.7368450674898455
Buffett classification: The Gruesome
Stock price: 7
Shares outstanding: 64697402
Book value: 227976432
P/B ratio: 1.9865290899894423
Market cap (USD): 452881814
Debt to equity: 0.01717865730962927
Current ratio: 24.00162059408513
Quick ratio: 24.00162059408513
Free cash flow (dilution-adjusted): -13440570
Buyback yield (%): 0
Retained earnings: -268740074
Capitalized R&D asset: 21657928.89
ROCI (R&D-adjusted, %): -6.1001149206487515
Rule of 40 score: 0
Financial ratios for IMRX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -13751943
Net income: -11579234
Capital expenditures: 123910
Operating cash flow: -9840598
Depreciation & amortization: 83206
Net tangible assets: 211472390
Owner earnings: -11619938
Return on net tangible assets (%): -5.494777828916578
Buffett classification: The Gruesome
Stock price: 6.58
Shares outstanding: 64697402
Book value: 218483968
P/B ratio: 1.9484674736409036
Market cap (USD): 425708905.16
Debt to equity: 0.01750437359321486
Current ratio: 17.495615969511167
Quick ratio: 17.495615969511167
Free cash flow (dilution-adjusted): -11602353
Buyback yield (%): 0
Retained earnings: -280320084
Capitalized R&D asset: 19986047.41
ROCI (R&D-adjusted, %): -6.072647822973742
Rule of 40 score: 0
Financial ratios for IMRX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -59375728
Net income: -56024657
Capital expenditures: 142226
Operating cash flow: -45344595
Depreciation & amortization: 353784
Net tangible assets: 211472390
Owner earnings: -55813099
Return on net tangible assets (%): -26.39261749488905
Buffett classification: The Gruesome
Stock price: 6.58
Shares outstanding: 64697402
Book value: 218483968
P/B ratio: 1.9484674736409036
Market cap (USD): 425708905.16
Debt to equity: 0.01750437359321486
Current ratio: 17.495615969511167
Quick ratio: 17.495615969511167
Free cash flow (dilution-adjusted): -51797956
Buyback yield (%): 0
Retained earnings: -280320084
Capitalized R&D asset: 87920526.9
ROCI (R&D-adjusted, %): -19.75466027879504
Rule of 40 score: 0
Financial ratios for IMSR — annual report dated 2024-12-31
Total revenue: 19018.03
Operating income: -9645538
Net income: -11485410
Capital expenditures: 607866
Operating cash flow: -8202934
Depreciation & amortization: 1256391
Net tangible assets: -14107524
Owner earnings: -10836885
Buffett classification: The Gruesome
Stock price: 10.02
Shares outstanding: 82718567
Book value: -13490552
Market cap (USD): 828840041.3399999
Debt to equity: -1.258930398103799
Current ratio: 2.9813217167646284
Quick ratio: 2.9813217167646284
Interest coverage ratio: -7.34710607197401
COGS to revenue (%): 0
R&D to revenue (%): 27221.17906008141
SG&A to revenue (%): 21919.073636964502
Free cash flow (dilution-adjusted): -9535447
Buyback yield (%): 0
Retained earnings: -96608242
Receivables turnover: 0.14752379474847768
Capitalized R&D asset: 9969383.71
ROCI (R&D-adjusted, %): -60.42589620130675
FCF margin (%): -50138.98390106652
Revenue growth (%): 2.1705705383044958
Rule of 40 score: -50136.81333052821
Financial ratios for IMSR — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -4855000
Net income: -6252000
Capital expenditures: 163000
Operating cash flow: -2760000
Depreciation & amortization: 181000
Net tangible assets: -17891626
Owner earnings: -6234000
Buffett classification: The Gruesome
Stock price: 10.52
Shares outstanding: 82718567
Book value: -17219233
Market cap (USD): 870199324.8399999
Debt to equity: -1.4995347934486978
Current ratio: 2.797413428995281
Quick ratio: 2.797413428995281
Interest coverage ratio: -3.541210795040117
Free cash flow (dilution-adjusted): -3124000
Buyback yield (%): 0
Retained earnings: -102284801
Capitalized R&D asset: 1408000
ROCI (R&D-adjusted, %): -35.70510470554624
Rule of 40 score: 0
Financial ratios for IMSR — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -5024717
Net income: -6249127
Capital expenditures: 362744
Operating cash flow: -4125147
Depreciation & amortization: 197737
Net tangible assets: -23925494
Owner earnings: -6414134
Buffett classification: The Gruesome
Stock price: 11.1
Shares outstanding: 82718567
Book value: -23268078
Market cap (USD): 918176093.6999999
Debt to equity: -1.1402282560682493
Current ratio: 1.1039782528090116
Quick ratio: 1.1039782528090116
Interest coverage ratio: -3.7803503999121255
Free cash flow (dilution-adjusted): -4706497
Buyback yield (%): 0
Retained earnings: -109109262
Capitalized R&D asset: 2384148
ROCI (R&D-adjusted, %): -58.30261429872894
Rule of 40 score: 0
Financial ratios for IMSR — annual report dated 2025-12-31
Total revenue: 0
Operating income: -24872979
Net income: -28016641
Capital expenditures: 1055307
Operating cash flow: -16472912
Depreciation & amortization: 1161704
Net tangible assets: 294698493
Owner earnings: -27910244
Return on net tangible assets (%): -9.470779343279506
Buffett classification: The Gruesome
Stock price: 6.11
Shares outstanding: 82718567
Book value: 295406242
P/B ratio: 1.7108996781794477
Market cap (USD): 505410444.37
Debt to equity: 0.007018253866145455
Current ratio: 50.62245318190982
Quick ratio: 50.62245318190982
Interest coverage ratio: -5.732143239865496
Free cash flow (dilution-adjusted): -20718071
Buyback yield (%): 0
Retained earnings: -124624883
Receivables turnover: 0
Capitalized R&D asset: 15597001.73
ROCI (R&D-adjusted, %): -7.187020266671859
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for IOF.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0024324324324324323
Shares outstanding: 191858408
Market cap (USD): 466682.614054054
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOF.L — annual report dated 2022-12-31
Total revenue: 50840963.85542169
Gross profit: 19071084.3373494
Operating income: 11579518.072289158
Net income: 9475903.614457833
Capital expenditures: 3719277.108433735
Operating cash flow: 6690361.445783133
Depreciation & amortization: 2196385.542168675
Net tangible assets: 41689156.62650602
Owner earnings: 7953012.048192773
Return on net tangible assets (%): 19.07693196925034
Capex to operating income (%): 32.11944646758922
Buffett classification: The Good
Stock price: 0.0024096385542168677
P/E ratio: 0.04878789777495232
Shares outstanding: 191858408
Book value: 45749397.590361446
P/B ratio: 0.010105256926156115
Market cap (USD): 462309.4168674699
Debt to equity: 0.18950805856947225
Current ratio: 2.9331715924128807
Quick ratio: 1.810101455668284
Effective tax rate (%): 21.585244267198405
Interest coverage ratio: 29.48159509202454
COGS to revenue (%): 62.48874354234798
SG&A to revenue (%): 3.066496042466467
Free cash flow (dilution-adjusted): 2795180.7228915663
Buyback yield (%): 0
Retained earnings: -26543373.493975904
Inventory turnover: 2.5892576590730556
Receivables turnover: 4.241005025125629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.02438241899262
FCF margin (%): 5.497890895303095
Rule of 40 score: 5.497890895303095
Financial ratios for IOF.L — annual report dated 2023-12-31
Total revenue: 63336708.86075949
Gross profit: 19815189.87341772
Operating income: 10930379.746835442
Net income: 8308860.75949367
Capital expenditures: 7891139.240506329
Operating cash flow: 10850632.911392404
Depreciation & amortization: 2716455.6962025315
Net tangible assets: 52607594.93670886
Owner earnings: 3134177.215189874
Return on net tangible assets (%): 5.957651588065449
Capex to operating income (%): 72.19455703532137
Buffett classification: The Good
Stock price: 0.0032911392405063286
P/E ratio: 0.07599510371724558
Shares outstanding: 191858408
Book value: 56645569.62025316
P/B ratio: 0.011147080688268154
Market cap (USD): 631432.7351898734
Debt to equity: 0.13048044692737432
Current ratio: 2.7946622620186043
Quick ratio: 1.9133269581848216
Effective tax rate (%): 21.04883329324032
Interest coverage ratio: 26.406727828746178
COGS to revenue (%): 68.71452554161004
SG&A to revenue (%): 2.865936525701495
Free cash flow (dilution-adjusted): 2688607.5949367085
Buyback yield (%): 0
Retained earnings: -19578481.012658227
Inventory turnover: 3.391398697968041
Receivables turnover: 3.4182265336794644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.615618433668576
FCF margin (%): 4.244943640578783
Revenue growth (%): 24.578104067563324
Rule of 40 score: 28.823047708142106
Financial ratios for IOF.L — annual report dated 2024-12-31
Total revenue: 68081250
Gross profit: 16546250
Operating income: 6170000
Net income: 3647500
Capital expenditures: 11891250
Operating cash flow: 14410000
Depreciation & amortization: 3233750
Net tangible assets: 55880000
Owner earnings: -5010000
Return on net tangible assets (%): -8.965640658554044
Capex to operating income (%): 192.72690437601295
Buffett classification: The Gruesome
Stock price: 0.002375
P/E ratio: 0.12492494009595613
Shares outstanding: 191858408
Book value: 59738750
P/B ratio: 0.007627607189638216
Market cap (USD): 455663.719
Debt to equity: 0.08911719779874872
Current ratio: 2.325692146258778
Quick ratio: 1.5136814916458148
Effective tax rate (%): 39.195665763700774
Interest coverage ratio: 18.55639097744361
COGS to revenue (%): 75.69631873680345
SG&A to revenue (%): 3.3581198935095933
Free cash flow (dilution-adjusted): 2365000
Buyback yield (%): 0
Retained earnings: -15587500
Inventory turnover: 4.098210735586481
Receivables turnover: 5.118890977443609
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.604420835522347
FCF margin (%): 3.473790507665473
Revenue growth (%): 7.490981493324814
Rule of 40 score: 10.964772000990287
Financial ratios for IOF.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 55880000
Buffett classification: The Gruesome
Stock price: 0.002375
Shares outstanding: 191858408
Book value: 59738750
P/B ratio: 0.007627607189638216
Market cap (USD): 455663.719
Debt to equity: 0.08911719779874872
Current ratio: 2.325692146258778
Quick ratio: 1.5136814916458148
Buyback yield (%): 0
Retained earnings: -15587500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOF.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 64706849.3150685
Buffett classification: The Gruesome
Stock price: 0.003287671232876712
Shares outstanding: 191858408
Book value: 68935616.43835616
P/B ratio: 0.009150093976909166
Market cap (USD): 630767.3687671232
Debt to equity: 0.14846094231266022
Current ratio: 2.4266256252404768
Quick ratio: 1.5475182762600999
Buyback yield (%): 0
Retained earnings: -13646575.342465755
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITP — annual report dated 2021-12-31
Total revenue: 25256156.98587127
Gross profit: 1729601.0989010988
Operating income: 260266.71899529043
Net income: 142156.20094191522
Capital expenditures: 3935851.1773940343
Operating cash flow: -382428.7284144427
Depreciation & amortization: 2411059.968602826
Net tangible assets: 31861828.257456828
Owner earnings: -1382635.0078492933
Return on net tangible assets (%): -4.339471660813143
Capex to operating income (%): 1512.2375971033216
Buffett classification: The Gruesome
Stock price: 2.3
P/E ratio: 274.49007318325636
Shares outstanding: 16965420
Book value: 33869687.284144424
P/B ratio: 1.1520763587996525
Market cap (USD): 39020466
Debt to equity: 0.07480645136590279
Current ratio: 2.7168049664603995
Quick ratio: 2.4307721624840366
Effective tax rate (%): 85.96611323165371
Interest coverage ratio: 1.4740784670072609
COGS to revenue (%): 93.1517645385691
SG&A to revenue (%): 5.941128675153399
Free cash flow (dilution-adjusted): -4318279.905808477
Buyback yield (%): 0
Retained earnings: 17291417.42543171
Inventory turnover: 25.640180191432012
Receivables turnover: 5.868747350282334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7498383656146054
FCF margin (%): -17.09792946022705
Rule of 40 score: -17.09792946022705
Financial ratios for ITP — annual report dated 2022-12-31
Total revenue: 14418453.16091954
Gross profit: 683074.1379310344
Operating income: -762144.683908046
Net income: -2380935.057471264
Capital expenditures: 1565880.8908045976
Operating cash flow: 1540141.9540229884
Depreciation & amortization: 2124717.8160919542
Net tangible assets: 17764033.333333332
Owner earnings: -1822098.1321839076
Return on net tangible assets (%): -10.25723211611425
Buffett classification: The Gruesome
Stock price: 0.46
Shares outstanding: 16965420
Book value: 26052283.333333332
P/B ratio: 0.299555056274658
Market cap (USD): 7804093.2
Debt to equity: 0.08516697292158279
Current ratio: 2.673741112065789
Quick ratio: 2.510899866439003
Interest coverage ratio: -5.160291687055122
COGS to revenue (%): 95.26250055878067
SG&A to revenue (%): 10.023397140521775
Free cash flow (dilution-adjusted): -48152.72988505747
Buyback yield (%): 0
Retained earnings: 13444686.925287357
Inventory turnover: 33.27908718933434
Receivables turnover: 4.732996785413348
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8395821595257953
FCF margin (%): -0.33396599030174
Revenue growth (%): -42.911135811416315
Rule of 40 score: -43.24510180171806
Financial ratios for ITP — annual report dated 2023-12-31
Total revenue: 12172566.807313642
Gross profit: 140630.8016877637
Operating income: -1135807.3136427565
Net income: -1398879.746835443
Capital expenditures: 3127889.8734177216
Operating cash flow: 1810279.3248945146
Depreciation & amortization: 2000842.475386779
Net tangible assets: 12212694.092827003
Owner earnings: -2525927.1448663855
Return on net tangible assets (%): -20.68280041788619
Buffett classification: The Gruesome
Stock price: 0.31
Shares outstanding: 16965420
Book value: 23676070.745428972
P/B ratio: 0.22213484055479873
Market cap (USD): 5259280.2
Debt to equity: 0.07358071060169394
Current ratio: 1.3239641618018898
Quick ratio: 1.1579785436567478
Interest coverage ratio: -8.202582380413563
COGS to revenue (%): 98.84469065634319
SG&A to revenue (%): 10.486186977126287
Free cash flow (dilution-adjusted): -1325145.428973277
Buyback yield (%): 0
Retained earnings: 11762163.99437412
Inventory turnover: 24.06228139630714
Receivables turnover: 5.832431537779651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.659225892856653
FCF margin (%): -10.886327016723294
Revenue growth (%): -15.576472236933537
Rule of 40 score: -26.462799253656833
Financial ratios for ITP — quarterly report dated 2024-09-30
Total revenue: 3577960.057061341
Gross profit: 273520.82738944364
Operating income: -208861.7689015692
Net income: -281590.0142653352
Capital expenditures: 36021.683309557775
Operating cash flow: 211807.98858773182
Depreciation & amortization: 496904.13694721827
Net tangible assets: 11689530.099857347
Owner earnings: 179292.43937232526
Buffett classification: The Gruesome
Stock price: 0.26
Shares outstanding: 16965420
Book value: 23441375.891583454
P/B ratio: 0.18817194094753448
Market cap (USD): 4411009.2
Debt to equity: 0.06335753236843701
Current ratio: 1.5887976096314729
Quick ratio: 1.3125922204131475
Interest coverage ratio: -8.540634661377823
COGS to revenue (%): 92.35539740446144
SG&A to revenue (%): 13.482056495823613
Free cash flow (dilution-adjusted): 175786.30527817406
Buyback yield (%): 0
Retained earnings: 11102818.402282454
Inventory turnover: 4.040813154520187
Receivables turnover: 1.5238775138222251
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8649945234833841
FCF margin (%): 4.913031517253754
Rule of 40 score: 4.913031517253754
Financial ratios for ITP — quarterly report dated 2024-12-31
Total revenue: 2416823.835616438
Gross profit: 152047.39726027398
Operating income: -505505.47945205483
Net income: -554091.095890411
Capital expenditures: 1980.6849315068494
Operating cash flow: 475117.5342465754
Depreciation & amortization: 530808.3561643836
Net tangible assets: 10375914.109589042
Owner earnings: -25263.424657534208
Return on net tangible assets (%): -0.24348143585909862
Buffett classification: The Gruesome
Stock price: 0.6
Shares outstanding: 16965420
Book value: 21376755.753424656
P/B ratio: 0.4761832018578982
Market cap (USD): 10179252
Debt to equity: 0.06152613582963758
Current ratio: 1.4126982756091833
Quick ratio: 1.295961133615135
Interest coverage ratio: -21.82175676794437
COGS to revenue (%): 93.70879271299918
SG&A to revenue (%): 27.207315114244246
Free cash flow (dilution-adjusted): 473136.8493150685
Buyback yield (%): 0
Retained earnings: 10107656.438356165
Inventory turnover: 7.029651223108701
Receivables turnover: 1.3067436623782585
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3444660448230317
FCF margin (%): 19.576803337608165
Revenue growth (%): -32.45246461467125
Rule of 40 score: -12.875661277063084